Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Max V Ranall
Affiliation
University of California San Francisco
ORCID
Career Start Year
2002
Papers
16
H Index
11
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36052495
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Cancer Res
2022
36052496
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Cancer Res
2022
34261774
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.
Clin Cancer Res
2021
29440171
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.
Cancer Res
2018
27872202
Genome-Wide Overexpression Screen Identifies Genes Able to Bypass p16-Mediated Senescence in Melanoma.
SLAS Discov
2017
27986750
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.
Clin Cancer Res
2017
26171227
Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells.
Pharmacol Res Perspect
2015
26516156
Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer.
Mol Cancer Ther
2015
24890688
Decatenation checkpoint-defective melanomas are dependent on PI3K for survival.
Pigment Cell Melanoma Res
2014
22391562
A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress.
Oncogene
2013
22664091
Resolving biofilm infections: current therapy and drug discovery strategies.
Curr Drug Targets
2012
23251614
Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of human ORFs and identification of human genes affecting viral titer.
PLoS One
2012
21629697
A high-throughput platform for lentiviral overexpression screening of the human ORFeome.
PLoS One
2011
21781051
High-content imaging of neutral lipid droplets with 1,6-diphenylhexatriene.
Biotechniques
2011
20569211
Adaptation and validation of DNA synthesis detection by fluorescent dye derivatization for high-throughput screening.
Biotechniques
2010
11872842
A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae.
Science
2002
1 - 16 of 16
Column Actions
Search
Recommended Authors
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Radek Fedr
Institute of Biophysics of the Czech Academy of Sciences
Career Start Year
2013
Number of shared co-authors
0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2010
Number of shared co-authors
0
Bhavneet Bhinder
Memorial Sloan Kettering Cancer Center, USA Memorial Sloan Kettering Cancer Center
Career Start Year
2010
Number of shared co-authors
0
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year
2009
Number of shared co-authors
0
Juan L Callejas-Valera
Cancer Biology Research Center
Career Start Year
2008
Number of shared co-authors
0
Yong-Jun Kwon
Luxembourg Institute of Health
Career Start Year
2007
Number of shared co-authors
0
Jarkko Ylanko
Sunnybrook Research Institute
Career Start Year
2007
Number of shared co-authors
0
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year
2005
Number of shared co-authors
0
Nicholas A Graham
University of Southern California
Career Start Year
2004
Number of shared co-authors
0
Susanne Heynen-Genel
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2002
Number of shared co-authors
0
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1998
Number of shared co-authors
0
Michael C Bassik
Stanford University Medical Center
Career Start Year
1997
Number of shared co-authors
1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Jason Moffat
University of Toronto
Career Start Year
1997
Number of shared co-authors
1
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year
1996
Number of shared co-authors
1
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year
1996
Number of shared co-authors
0
Krister Wennerberg
University of Copenhagen
Career Start Year
1994
Number of shared co-authors
0
Yu-Tsueng Liu
University of California San Diego
Career Start Year
1994
Number of shared co-authors
0
Jeremy S Caldwell
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year
1994
Number of shared co-authors
1
David E Root
Broad Institute of Harvard and MIT
Career Start Year
1993
Number of shared co-authors
0
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year
1992
Number of shared co-authors
0
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year
1989
Number of shared co-authors
1
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year
1987
Number of shared co-authors
0
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year
1984
Number of shared co-authors
0
Robert H Shoemaker
National Cancer Institute
Career Start Year
1978
Number of shared co-authors
0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year
1976
Number of shared co-authors
11
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year
1968
Number of shared co-authors
0
Norman E Sharpless
National Cancer Institute
Career Start Year
1945
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers
5
Stefan Hartmann
University Hospital Wurzburg
Co-authored papers
5
Toni M Brand
University of Wisconsin School of Medicine and Public Health
Co-authored papers
5
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers
5
Daniel E Johnson
University of California San Francisco
Co-authored papers
5
Jennifer R Grandis
University of California san francisco
Co-authored papers
5
Yan Zeng
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers
5
Sourav Bandyopadhyay
University of California San Francisco
Co-authored papers
5
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Co-authored papers
5
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
3
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers
3
Hua Li
University of California san francisco
Co-authored papers
3
Rachel A O'Keefe
University of California San Francisco
Co-authored papers
3
Julie E Bauman
George Washington University
Co-authored papers
3
Carolyn Kemp
University of Pittsburgh Medical Center, Eye and Ear Institute
Co-authored papers
3
Michelle A Ozbun
The University of New Mexico School of Medicine
Co-authored papers
3
Sean M Grimmond
The University of Melbourne
Co-authored papers
1
Mushfiq H Shaikh
University of Western Ontario
Co-authored papers
1
Antje Blumenthal
Frazer Institute, The University of Queensland
Co-authored papers
1
1 - 19